KR19990063637A - 주요 조직적합 복합체(mhc) 클래스 ⅱ 펩티드를 이용한 면역응답 억제방법 및 조성물 - Google Patents
주요 조직적합 복합체(mhc) 클래스 ⅱ 펩티드를 이용한 면역응답 억제방법 및 조성물 Download PDFInfo
- Publication number
- KR19990063637A KR19990063637A KR1019980702086A KR19980702086A KR19990063637A KR 19990063637 A KR19990063637 A KR 19990063637A KR 1019980702086 A KR1019980702086 A KR 1019980702086A KR 19980702086 A KR19980702086 A KR 19980702086A KR 19990063637 A KR19990063637 A KR 19990063637A
- Authority
- KR
- South Korea
- Prior art keywords
- peptide
- cells
- class
- sequence
- peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US411795P | 1995-09-21 | 1995-09-21 | |
| US60/004,117 | 1995-09-21 | ||
| PCT/US1996/015662 WO1997010711A1 (en) | 1995-09-21 | 1996-09-23 | Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR19990063637A true KR19990063637A (ko) | 1999-07-26 |
Family
ID=21709234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019980702086A KR19990063637A (ko) | 1995-09-21 | 1996-09-23 | 주요 조직적합 복합체(mhc) 클래스 ⅱ 펩티드를 이용한 면역응답 억제방법 및 조성물 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0914041A4 (hu) |
| JP (1) | JPH11513377A (hu) |
| KR (1) | KR19990063637A (hu) |
| AU (1) | AU7202596A (hu) |
| BR (1) | BR9610625A (hu) |
| CA (1) | CA2230119A1 (hu) |
| HU (1) | HUP9901795A2 (hu) |
| IL (1) | IL123759A0 (hu) |
| NO (1) | NO981201D0 (hu) |
| WO (1) | WO1997010711A1 (hu) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7247438B1 (en) | 1997-02-18 | 2007-07-24 | Dana-Farber Cancer Institute | Methods of identifying agents which enhance caspase activity |
| JP2014133703A (ja) * | 2011-03-30 | 2014-07-24 | Clio Inc | 生体組織から単離できるｓｓｅａ−３陽性の多能性幹細胞を含む他家移植用細胞治療用組成物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08502244A (ja) * | 1992-08-11 | 1996-03-12 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 免疫調節ペプチド |
-
1996
- 1996-09-23 WO PCT/US1996/015662 patent/WO1997010711A1/en not_active Application Discontinuation
- 1996-09-23 CA CA002230119A patent/CA2230119A1/en not_active Abandoned
- 1996-09-23 HU HU9901795A patent/HUP9901795A2/hu unknown
- 1996-09-23 AU AU72025/96A patent/AU7202596A/en not_active Abandoned
- 1996-09-23 IL IL12375996A patent/IL123759A0/xx unknown
- 1996-09-23 JP JP9512976A patent/JPH11513377A/ja active Pending
- 1996-09-23 KR KR1019980702086A patent/KR19990063637A/ko not_active Application Discontinuation
- 1996-09-23 BR BR9610625A patent/BR9610625A/pt not_active Application Discontinuation
- 1996-09-23 EP EP96933201A patent/EP0914041A4/en not_active Withdrawn
-
1998
- 1998-03-17 NO NO981201A patent/NO981201D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0914041A4 (en) | 2000-06-28 |
| HUP9901795A2 (hu) | 1999-09-28 |
| CA2230119A1 (en) | 1997-03-27 |
| NO981201L (no) | 1998-03-17 |
| BR9610625A (pt) | 1999-03-16 |
| WO1997010711A1 (en) | 1997-03-27 |
| IL123759A0 (en) | 1998-10-30 |
| AU7202596A (en) | 1997-04-09 |
| NO981201D0 (no) | 1998-03-17 |
| EP0914041A1 (en) | 1999-05-12 |
| JPH11513377A (ja) | 1999-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Westermark et al. | Senile cardiac amyloidosis: evidence of two different amyloid substances in the ageing heart | |
| Chattopadhyay et al. | Lack of suppressor cell activity in rheumatoid synovial lymphocytes. | |
| JP4522367B2 (ja) | 新規ペプチド | |
| US5681556A (en) | Method and compositions for suppressing allograft rejection in mammals | |
| MXPA03001606A (es) | Metodo de seleccion de peptidos. | |
| JP3434510B2 (ja) | ミエリン塩基性タンパク質のペプチドフラグメントを用いたｔ‐細胞増殖の抑制 | |
| AU670024B2 (en) | Methods of treating or preventing autoimmune uveoretinitis in mammals | |
| AU665403B2 (en) | Use of ruthenium red for inhibiting immune response | |
| JP2003231698A (ja) | 自己免疫性を改善せしめるうえで有用なｍｈｃコンジュゲート | |
| JPH10501791A (ja) | クラスｉｍｈｃペプチドによる細胞傷害性ｔ細胞リンパ球（「ｃｔｌ」）活性の調節 | |
| JPH05502434A (ja) | 医薬組成物およびその用途 | |
| KR19990063637A (ko) | 주요 조직적합 복합체(mhc) 클래스 ⅱ 펩티드를 이용한 면역응답 억제방법 및 조성물 | |
| EP1389219B1 (en) | Dimerized t-cell receptor fragment, its compositions and use | |
| US20050048067A1 (en) | Peptides capable of modulating immune response | |
| Hirohata | Inhibition of human B cell activation by gold compounds | |
| JPH11510806A (ja) | 免疫抑制治療のためのインターロイキン１０およびシクロスポリンの併用 | |
| JPH07196508A (ja) | 移植片対宿主疾患の治療のための医薬組成物 | |
| Pedersen et al. | Impaired release of natural killer cytotoxic factor in patients with primary Sjögren's syndrome. | |
| JP2002513558A (ja) | ミエリン塩基性タンパク質ペプチドおよびその使用 | |
| Chae et al. | T Cell-specific immunosuppression using tautomycetin or PTD-conjugated protein drugs | |
| Youinou et al. | Monoclonal antibody analysis of blood and cornea T lymphocyte subpopulations in herpes simplex keratitis | |
| Weiss et al. | Effects of cyclosporin A on functions of specific murine T cell clones: inhibition of proliferation, lymphokine secretion and cytotoxicity | |
| EP3958887B1 (en) | Medical uses for inducing or restoring immune tolerance | |
| KR20050054119A (ko) | 잔소리졸을 함유하는 면역억제제 | |
| Pedersen et al. | Suppressed natural killer cell activity in patients with euthyroid Graves' ophthalmopathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |